StartsideCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
193,03 $
Etterbørs:(0,00 %)0,00
193,03 $
Stengt: 12. des., 18:11:01 GMT-5 · USD · NYSE · Ansvarsfraskrivelse
Forrige sluttkurs
194,43 $
Dagsintervall
192,09 $ - 195,51 $
Årsintervall
91,86 $ - 199,66 $
Markedsverdi
9,50 mrd. USD
Gjennomsnittlig volum
1,03 mill.
P/E-tall
-
Utbytte
-
Hovedbørs
NYSE
I nyhetene
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
| (USD) | sep. 2025info | Endring år til år |
|---|---|---|
Omsetning | 1,00 mrd. | −0,49 % |
Driftskostnader | 193,65 mill. | −9,43 % |
Nettoomsetning | 54,42 mill. | −21,87 % |
Netto resultatmargin | 5,42 | −21,45 % |
Fortjeneste per aksje | 2,43 | −6,18 % |
EBITDA | 172,65 mill. | −28,70 % |
Faktisk avgiftssats | 36,29 % | — |
Balanseregnskap
Totale aktiva
Totale passiva
| (USD) | sep. 2025info | Endring år til år |
|---|---|---|
Kontant / kortsiktige inv. | 207,10 mill. | −1,46 % |
Totale aktiva | 7,51 mrd. | −6,12 % |
Totale passiva | 4,06 mrd. | −2,71 % |
Total egenkapital | 3,45 mrd. | — |
Utestående aksjer | 49,22 mill. | — |
P/B-forhold | 2,81 | — |
Avkastning på aktiva | 5,26 % | — |
Avkastning på kapital | 6,46 % | — |
Kontantstrøm
Netto kontantstrøm
| (USD) | sep. 2025info | Endring år til år |
|---|---|---|
Nettoomsetning | 54,42 mill. | −21,87 % |
Kontantstrøm fra drift | 213,83 mill. | −15,08 % |
Kontanter fra investering | −33,70 mill. | −58,02 % |
Kontanter fra finansiering | −152,62 mill. | 26,46 % |
Netto kontantstrøm | 24,48 mill. | −20,09 % |
Fri kontantstrøm | 65,54 mill. | −71,13 % |
Om
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Administrerende direktør
Grunnlagt
1947
Hovedkvarter
Nettsted
Ansatte
19 400